Russian Federation - Pharmaceutical Industry

Case Study – Pharmaceutical Industry The Russian pharmaceuticals market grew by 7.8% in 2010 to reach a value of $13,411.9 million Russia accounts for 6.3% of the European pharmaceuticals market value Novartis is the leading player in the Russian pharmaceuticals market, generating a 3.7% share of the market's value The Russian pharmaceutical market is characterized by fairly strong buyer power, with the ease of market entry strongly affected by legal and regulatory frameworks Companies on pharm market in Russia USD MM 2005 2010 CAGR, % Market share 2010, % 1 Phamstandard 136 416 3.1% 25 ВayerAG 170 376 17 28% Novartis 318 496 3.7% Sanofi-Aventis 372 389 2.9% Source: 2010 IMS research for 2005, 2012 Datamonitor research for 2010 data